Get started
Work

Updated Safety and Efficacy from a Phase I Study of Azd9291 in Patients (Pts) with Egfr-Tki-Resistant Non-Small Cell Lung Cancer (Nsclc)

Year: 2014
Type: article
DOI: 10.1093/annonc/mdu331.9
Authors: J.C. Yang, D. Kim, D. Planchard, Y. Ohe, S.S. Ramalingam, M. Ahn, S. Kim, W. Su, L. Horn, D. Haggstrom, E. Felip, J. Kim, P. Frewer, M. Cantarini, S. Ghiorghiu, M. Ranson, P.A. Janne
Institutions: National Taiwan University Hospital, Seoul National University, Seoul National University Hospital, Institut Gustave Roussy, National Cancer Center Hospital East, Emory University, Winship Cancer Institute, Samsung Medical Center, Sungkyunkwan University, Asan Medical Center, National Cheng Kung University Hospital, National Cheng Kung University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Levine Cancer Institute, Vall d'Hebron Hospital Universitari, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, AstraZeneca (United Kingdom), University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust, Dana-Farber Cancer Institute
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2183775298
FWCI: 4.619
Cites:
Cited by: 20
Related to: 10